Cambridge
-
Malvern-based Galera Therapeutics to Be Acquired In Reverse Merger
Malvern-based Galera Therapeutics will be acquired by Obsidian Therapeutics in an all-stock reverse merger, writes John George for the Philadelphia Business Journal. The two companies have secured a $350 million private…
-
TLC: Fostering a Child’s Love for Reading in the Digital Age
Many of us remember those hot, languid summer days spent reading the newest novel by the author we loved or about our latest faddish obsession…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
